Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9880
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMehta, Priti Jignesh-
dc.contributor.authorKhatri, Deepak Mohanlal-
dc.date.accessioned2021-08-09T06:39:08Z-
dc.date.available2021-08-09T06:39:08Z-
dc.date.issued2011-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9880-
dc.descriptionJournal of Planar Chromatography, 24; 2011: 412-418en_US
dc.description.abstractA simple, specific, precise and accurate stability-indicating assay method using high performance thin-layer chromatography (HPTLC) is described for estimation of Milnacipran hydrochloride (MIL) in bulk drug and in pharmaceutical formulations. The sepa rations were achieved on prepared TLC plates precoated with silica gel 60 F254. The mobile phase developed and optimized for bringing out the separation involves chloroform–methanol–ammonia in the ratio of 6.4:2.5:0.2 v/v/v. The densitometric scanning wavelength selected was 220 nm. The compact bands of MIL were obtained at RF value of 0.45 ± 0.02. The method developed was able to separate peaks of all the degradation products formed in ICH-prescribed stress conditions with sufficient difference in their RF values. The developed method was validated for linearity and range, specificity, precision, accuracy and robustness, and the results were found to be within acceptance criteria. The reliability of the method was evalu ated when it was applied for the estimation of MIL in pharmaceuti cal capsule formulation, and assay results gave good recovery when statistically compared with the reversed-phase high-performance liquid chromatography (RP-HPLC) method.en_US
dc.publisherSpringeren_US
dc.relation.ispartofseriesIPFP0350;-
dc.subjectMilnacipran hydrochlorideen_US
dc.subjectHPTLCen_US
dc.subjectStress studiesen_US
dc.subjectValidationen_US
dc.subjectPharmaceutical formulationen_US
dc.subjectMethod comparisonen_US
dc.titleStability-Indicating HPTLC Method for Determination of Milnacipran Hydrochloride in Pharmaceutical Formulationsen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0350.pdfIPFP03501 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.